Skip to Content

MYLAN 6725 MYLAN 6725 (Zonisamide 25 mg)

Pill with imprint MYLAN 6725 MYLAN 6725 is Purple, Capsule-shape and has been identified as Zonisamide 25 mg. It is supplied by Mylan Pharmaceuticals Inc..

Zonisamide is used in the treatment of migraine prevention; seizures; parkinsonian tremor; benign essential tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 6725 MYLAN 6725

Zonisamide 25 mg MYLAN 6725 MYLAN 6725
Zonisamide 25 mg MYLAN 6725 MYLAN 6725
Zonisamide 25 mg MYLAN 6725 MYLAN 6725
Zonisamide 25 mg MYLAN 6725 MYLAN 6725

Zonisamide

Imprint:
MYLAN 6725 MYLAN 6725
Strength:
25 mg
Color:
Purple
Size:
12.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
lactose anhydrous
ferrosoferric oxide
silicon dioxide
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
gelatin
magnesium stearate
microcrystalline cellulose
propylene glycol
shellac
sodium lauryl sulfate
titanium dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide